OptimizeRx (OPRX) Competitors $18.83 +1.27 (+7.23%) Closing price 09/11/2025 04:00 PM EasternExtended Trading$18.60 -0.23 (-1.25%) As of 04:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OPRX vs. PRG, GDRX, CTOS, CRTO, TIXT, EVH, MPLN, YEXT, MEG, and RDWRShould you be buying OptimizeRx stock or one of its competitors? The main competitors of OptimizeRx include Aaron's (PRG), GoodRx (GDRX), Custom Truck One Source (CTOS), Criteo (CRTO), Telus Digital (TIXT), Evolent Health (EVH), MultiPlan (MPLN), Yext (YEXT), Montrose Environmental Group (MEG), and Radware (RDWR). These companies are all part of the "business services" industry. OptimizeRx vs. Its Competitors Aaron's GoodRx Custom Truck One Source Criteo Telus Digital Evolent Health MultiPlan Yext Montrose Environmental Group Radware OptimizeRx (NASDAQ:OPRX) and Aaron's (NYSE:PRG) are both small-cap business services companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, dividends, risk, earnings, analyst recommendations and valuation. Which has more risk & volatility, OPRX or PRG? OptimizeRx has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500. Comparatively, Aaron's has a beta of 1.77, suggesting that its stock price is 77% more volatile than the S&P 500. Which has preferable valuation and earnings, OPRX or PRG? Aaron's has higher revenue and earnings than OptimizeRx. OptimizeRx is trading at a lower price-to-earnings ratio than Aaron's, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOptimizeRx$92.13M3.80-$18.66M-$0.54-34.87Aaron's$2.46B0.58$197.25M$5.067.20 Does the media prefer OPRX or PRG? In the previous week, OptimizeRx had 3 more articles in the media than Aaron's. MarketBeat recorded 11 mentions for OptimizeRx and 8 mentions for Aaron's. Aaron's' average media sentiment score of 1.49 beat OptimizeRx's score of 1.04 indicating that Aaron's is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OptimizeRx 7 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aaron's 6 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders have more ownership in OPRX or PRG? 76.5% of OptimizeRx shares are held by institutional investors. Comparatively, 97.9% of Aaron's shares are held by institutional investors. 5.6% of OptimizeRx shares are held by company insiders. Comparatively, 3.2% of Aaron's shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is OPRX or PRG more profitable? Aaron's has a net margin of 8.53% compared to OptimizeRx's net margin of -9.42%. Aaron's' return on equity of 22.54% beat OptimizeRx's return on equity.Company Net Margins Return on Equity Return on Assets OptimizeRx-9.42% 4.50% 3.12% Aaron's 8.53%22.54%9.98% Do analysts recommend OPRX or PRG? OptimizeRx currently has a consensus price target of $11.81, suggesting a potential downside of 37.27%. Aaron's has a consensus price target of $41.00, suggesting a potential upside of 12.54%. Given Aaron's' higher possible upside, analysts plainly believe Aaron's is more favorable than OptimizeRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OptimizeRx 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 2.83Aaron's 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.71 SummaryAaron's beats OptimizeRx on 11 of the 16 factors compared between the two stocks. Get OptimizeRx News Delivered to You Automatically Sign up to receive the latest news and ratings for OPRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OPRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPRX vs. The Competition Export to ExcelMetricOptimizeRxCOMP IndustryComputer SectorNASDAQ ExchangeMarket Cap$326M$176.92B$31.33B$10.07BDividend YieldN/A1.25%3.18%4.62%P/E Ratio-34.8739.31439.2126.20Price / Sales3.807.031,822.8991.87Price / CashN/A27.2836.4459.91Price / Book2.979.557.256.28Net Income-$18.66M$4.39B$807.55M$270.85M7 Day Performance0.05%1.72%3.20%3.58%1 Month Performance14.82%5.10%5.24%6.67%1 Year Performance152.41%10.31%24,265.92%27.73% OptimizeRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPRXOptimizeRx1.6088 of 5 stars$18.83+7.2%$11.81-37.3%+158.7%$326M$92.13M-34.87100Positive NewsInsider TradePRGAaron's3.5947 of 5 stars$35.48+0.4%$41.00+15.6%-18.4%$1.40B$2.46B7.011,403Positive NewsGDRXGoodRx4.0631 of 5 stars$4.12+3.0%$5.80+40.8%-43.7%$1.39B$792.32M41.20950Positive NewsShort Interest ↑CTOSCustom Truck One Source2.0319 of 5 stars$5.89-3.4%$6.38+8.3%+71.4%$1.38B$1.80B-36.781,800Positive NewsCRTOCriteo4.0275 of 5 stars$23.75+1.8%$40.00+68.4%-50.2%$1.35B$1.93B9.943,507Positive NewsTIXTTelus Digital2.173 of 5 stars$4.51+0.8%$3.93-12.7%+22.3%$1.24B$2.66B-3.2478,879EVHEvolent Health2.0263 of 5 stars$9.66+0.5%$18.07+87.2%-69.1%$1.13B$2.20B-6.004,500Analyst ForecastMPLNMultiPlan0.5971 of 5 stars$69.82+3.2%$12.50-82.1%N/A$1.13B$930.62M-0.73170Positive NewsYEXTYext1.8886 of 5 stars$8.81-1.6%$9.44+7.2%+34.0%$1.10B$420.96M-48.911,150MEGMontrose Environmental Group2.4955 of 5 stars$29.06-4.4%$32.00+10.1%+9.2%$1.07B$696.40M-19.243,410Positive NewsShort Interest ↓RDWRRadware4.3229 of 5 stars$25.55+2.2%$32.50+27.2%+30.4%$1.07B$274.88M79.851,208Gap Up Related Companies and Tools Related Companies Aaron's Alternatives GoodRx Alternatives Custom Truck One Source Alternatives Criteo Alternatives Telus Digital Alternatives Evolent Health Alternatives MultiPlan Alternatives Yext Alternatives Montrose Environmental Group Alternatives Radware Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OPRX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OptimizeRx Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share OptimizeRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OPRX Stock Alerts